Viewing nowDapaHana 10mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

MFDS item code 202200237 · Approved 2022.01.13 · Insurance code 645210640
Improvement of blood glucose control in patients with type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with other medications. Particularly, in patients who have difficulty controlling blood sugar and who have cardiovascular disease or risk factors, careful consideration should be given to the cardiovascular effects of the medication. Overall, this medication helps with blood sugar management and prevents related complications in patients with type 2 diabetes.
Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other antihyperglycemic agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior antidiabetic drug treatment, the recommended initial dose of this medicine when administered with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablets should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There are no relevant data.
This medication should not be used in patients with hypersensitivity to the active ingredient or excipients, type 1 diabetes, diabetic ketoacidosis, and patients undergoing dialysis. It should be administered with caution to patients with reduced fluid volume or renal dysfunction, as hypotension or rapid changes in kidney function may occur, requiring thorough monitoring of the patient's condition before and during administration. The blood sugar control effect of this medication differs based on renal function, and particularly in patients with moderate to severe impairment of kidney function, the blood sugar control effect may be reduced, necessitating caution. The most commonly reported side effect in clinical trials is genital infections, which may occur more frequently in women and patients with a history of infections. Additionally, hypoglycemia may occur, so when used with insulin or sulfonylureas and other blood glucose-lowering agents, dosage adjustment may be required to reduce the risk of hypoglycemia. Symptoms of dehydration or hypotension due to reduced fluid volume may occur, especially in elderly patients or those on diuretics, requiring additional caution; if symptoms appear, the medication may be temporarily discontinued. The risk of diabetic ketoacidosis is present, so if ketoacidosis symptoms appear regardless of blood glucose levels, immediate testing and treatment should be sought. This medication may increase the risk of urinary tract infections and pyelonephritis, thus rapid evaluation and treatment are necessary if infection symptoms occur. Serious infections such as Fournier's gangrene are rarely reported, and if symptoms such as pain, swelling, or redness in the genitals or perineum appear, medical attention should be sought immediately. Women who are pregnant or planning to become pregnant should not use this medication, and its use is also recommended against for nursing mothers. The safety and efficacy of this medication in children under 18 years of age have not been established and use is not recommended. In case of overdose, there is no specific antidote, so it is important to receive appropriate treatment based on symptoms. This medication does not significantly affect driving or machine operation, but caution is required if there is a risk of hypoglycemia. Lastly, this medication should be stored out of the reach of children, and kept in its original container to maintain quality.
vulvitis, balanitis and related genitourinary infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, decreased serum creatinine clearance at the beginning of treatment, dyslipidemia, elevated serum creatinine at the beginning of treatment, increased serum urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, intracerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, depression, suicide attempts, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulosis, pneumoperitoneum, frequent bowel movements, gastroenteritis, colorectal polyps, bowel perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, nephrolithiasis, abnormal urination, increased blood lactate, lymphocytopenia, vitamin D deficiency, increased appetite, taste alteration, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, shingles, sinusitis, tonsillitis, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like syndrome, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genitourinary rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, itching, urticaria, sweating, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is best stored at room temperature between 1 to 30 degrees Celsius.
Yellow, double convex, diamond-shaped film-coated tablet
Bottle - 28 tablets/bottle, Bottle - 30 tablets/bottle, Box - 28 tablets/box [7 tablets/Alu-Alu x 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.